USE OF CYTOKINE SYNTHESIS INHIBITORS FOR THE TREATMENT OF DRY EYE DISORDERS

Details for Australian Patent Application No. 2003278727 (hide)

Owner ALCON, INC.

Inventors Gamache, Daniel A.

Agent Spruson & Ferguson

Pub. Number AU-A-2003278727

PCT Number PCT/US03/26689

PCT Pub. Number WO2004/026406

Priority 60/412,463 20.09.02 US

Filing date 26 August 2003

Wipo publication date 8 April 2004

International Classifications

A61P 027/02 Drugs for disorders of the senses

A61K 031/505 - Pyrimidines

A61K 031/506 - not condensed and containing further heterocyclic rings

A61K 031/192

A61K 031/616

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 038/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 031/416 - condensed with carbocyclic ring systems, e.g. indazole

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 60/412,463 20.09.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-A-2003278727

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278728-Method for cancer therapy using herbal extracts

2003278726-SINTERED GLASS BEAD FILTER WITH ACTIVE MICROBIAL DESTRUCTION